Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

AIMS: As promising compounds to lower Lipoprotein(a) (Lp(a)) are emerging, the need for a precise characterization and comparability of the Lp(a)-associated cardiovascular risk is increasing. Therefore, we aimed to evaluate the distribution of Lp(a) concentrations across the European population, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Waldeyer, Christoph, Makarova, Nataliya, Zeller, Tanja, Schnabel, Renate B., Brunner, Fabian J., Jørgensen, Torben, Linneberg, Allan, Niiranen, Teemu, Salomaa, Veikko, Jousilahti, Pekka, Yarnell, John, Ferrario, Marco M., Veronesi, Giovanni, Brambilla, Paolo, Signorini, Stefano G., Iacoviello, Licia, Costanzo, Simona, Giampaoli, Simona, Palmieri, Luigi, Meisinger, Christa, Thorand, Barbara, Kee, Frank, Koenig, Wolfgang, Ojeda, Francisco, Kontto, Jukka, Landmesser, Ulf, Kuulasmaa, Kari, Blankenberg, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837491/
https://www.ncbi.nlm.nih.gov/pubmed/28449027
http://dx.doi.org/10.1093/eurheartj/ehx166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837491/
https://www.ncbi.nlm.nih.gov/pubmed/28449027
http://dx.doi.org/10.1093/eurheartj/ehx166

Ejemplares similares